![]() |
![]() |
![]() |
|
Obsessive Compulsive Disorder |
Overcoming Anxiety (Home) > Obsessive Compulsive Disorder > Specific Clinical Response Specific Clinical Response for OCDReports that clomipramine (CMI), a tricyclic antidepressant with a serotonergic profile, is effective in treating symptoms of OCD has directed researchers’ interest in the relationship between serotonin and OCD. Moreover, OCD is currently unique among psychiatric disorders, as only serotonergic medications appear to be effective in this disorder. For example, non-serotonergic drugs, such as desipramine (DMI), which are effective in depression and panic disorder, are entirely ineffective in OCD. While this does not necessarily reflect on pathogenesis, the specific response to serotonergic drugs has paved the way for further research on the role of serotonin in the pathogenesis of OCD in particular, and in OCD-related disorders in general. As yet, abnormality of the serotonergic system and particularly hypersensitivity of post-synaptic 5-HT (hydroxy tryptamine) receptors, constitute the leading hypothesis for the underlying pathophysiology of OCD.
|
Bookmark This Page: Add to Favorites Add to Del.icio.us Send to a Friend Resources: |
|||||||||||||||||